Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > COIN Hosts Risk vs. Reward: Financing Early-Stage, Emerging Technologies NanoBio Executive Roundtable

Abstract:
The Center of Innovation for Nanobiotechnology (COIN) has announced the upcoming NanoBio Executive Roundtable event to be hosted at The Hawthorne Inn in Winston-Salem, NC on July 14, 2011. This Roundtable will address a significant hurdle to nanobiotechnology development and commercialization—early-stage funding. The "Risk vs. Reward: Financing Early-Stage, Emerging Technologies" brings together a panel of seasoned investors and entrepreneurs to discuss the risk involved in investing in early-stage platform nanobiotechnologies. The panelists will also discuss how entrepreneurs in this space can more effectively approach the appropriate investors to accelerate commercialization.

COIN Hosts Risk vs. Reward: Financing Early-Stage, Emerging Technologies NanoBio Executive Roundtable

Durham, NC | Posted on June 30th, 2011

The expert panelists include Scott Albert, a former Venture Partner with Aurora Funds and now with Centice, who just announced a $2.3m round of funding. Christy Shaffer, a former CEO of Inspire Pharmaceuticals and recently joined as a Venture Partner and Managing Director at Hatteras Venture Partners, an early stage fund for life sciences. Steven Walsh, an experienced serial entrepreneur at the University of New Mexico and founder of MANCEF. Mr. Walsh has raised over $200m for several nanotechnology related ventures in recent years. This panel will be moderated by Andy Dreyfuss, a Fund Executive at the Winston Salem based Piedmont Angel Network, who has invested in nanotechnology companies like Protochips.

This NanoBio Executive Roundtable event series offers executives and entrepreneurs of North Carolina-based nanobiotechnology companies and others involved in this exciting field an opportunity to discuss key business issues and build relationships. In total, the previous four Roundtables have attracted over 500 attendees from eight states. "The COIN Roundtable events provide unique opportunities to meet and interact with the movers and shakers of Nanobiotech in NC...an event you can't miss" -Anil Goyal, President, CEO, Qualiber Inc.

COIN coordinates these Roundtables to stimulate dialogue in the community and be a catalyst for relationship-building that is critical for accelerating the commercialization of nanobiotechnology. COIN is a non-profit that is a single point of entry into the nanobiotech community and offers high-value programs and services that are designed to help accelerate innovation management and new product development and commercialization in the area of nanobiotechnology and nanomedicine.

Risk vs. Reward: Financing Early-Stage, Emerging Technologies is a key topic of discussion for the growing nanobiotechnology sector. COIN has invited these experts to discuss the critical issue of funding for emerging technologies. Without appropriate early-stage funding that allows continued development , many promising emerging technologies are at risk of running out of resources. The NanoBio Executive Roundtable event will be held at the Hawthorne Inn (420 High Street, Winston-Salem, NC) on July 14, 2011 from 5:30 to 7:30 pm, with registration opening at 5 pm. Attendees will also enjoy a gala networking reception that facilitates connections that lead to collaborations and new business relationships. There are several generous sponsors for the NanoBio Executive Roundtable series, including RTI International, McDonnell Boehnen Hulbert & Berghoff LLP (MBHB), MEMSCAP, and Grant Thornton. Prasidiux has generously sponsored the networking reception at this Risk vs. Reward: Financing Early-Stage, Emerging Technologies event and RTI International sponsored speaker travel.

To register for this free event, please visit riskvsrewardjuly.eventbrite.com/.

####

About The Center of Innovation for Nanobiotechnology (COIN)
COIN is a nonprofit organization that accelerates commercialization of nanobiotechnology and nanomedicine to enable economic growth and improve human life. North Carolina is a leader in these fields and in related new product innovation and entrepreneurship. Established with funding from the NC Biotechnology Center, COIN represents a targeted state resource to encourage development of commercial applications of nanobiotechnology in key life science and medical product sectors. COIN provides a framework to boost the profile, funding, and management of the important work occurring in nanobiotechnology in the state, with the ultimate goal being commercialization. COIN’s programs and services address key issues of its clients such as early-stage funding, preclinical testing, technology scouting, and industry partnering.

For more information, please click here

Contacts:
Dr. Laura Faulconer
Director, Innovation Projects
The Venable Center
303 South Roxboro St., Suite 30
Durham, NC 27701

Office: (919) 680-2070 ext 301

Copyright © The Center of Innovation for Nanobiotechnology (COIN)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Switching to spintronics: Berkeley Lab reports on electric field switching of ferromagnetism at room temp December 17th, 2014

ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014

Harris & Harris Group to Host Conference Call on Third Quarter 2014 Financial Results on November 12, 2014 November 3rd, 2014

Announcements

Switching to spintronics: Berkeley Lab reports on electric field switching of ferromagnetism at room temp December 17th, 2014

ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

Events/Classes

Bruker Introduces BioScope Resolve High-Resolution BioAFM System: Featuring PeakForce Tapping for Quantitative Bio-Mechanical Property Mapping December 16th, 2014

TCL Launches World’s Most Advanced TV in the World’s Largest Market: New Quantum Dot TVs with Color IQ™ Optics Deliver OLED-Quality Color at a Fraction of the Price December 15th, 2014

Stanford team combines logic, memory to build a 'high-rise' chip: Today circuit cards are laid out like single-story towns; Futuristic architecture builds layers of logic and memory into skyscraper chips that would be smaller, faster, cheaper -- and taller December 15th, 2014

PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE